.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Chinese Patent Office
Chubb
Novartis
QuintilesIMS
Queensland Health
McKinsey
Cerilliant
Julphar
Express Scripts

Generated: September 24, 2017

DrugPatentWatch Database Preview

Neomycin sulfate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for neomycin sulfate and what is the scope of neomycin sulfate patent protection?

Neomycin sulfate
is the generic ingredient in fourteen branded drugs marketed by Teva, Lannett, X Gen Pharms, Pharmacia And Upjohn, Lannett Holdings Inc, Bristol Myers Squibb, Oman Pharm Products, Roxane, Pfizer, Lilly, Sandoz, Monarch Pharms, Alcon, Watson Labs, Glaxosmithkline, Allergan, Merck, Fougera, Pharmaderm, and Savage Labs, and is included in thirty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for neomycin sulfate. Seven suppliers are listed for this compound.

Summary for Generic Name: neomycin sulfate

Tradenames:14
Patents:0
Applicants:20
NDAs:32
Drug Master File Entries: see list18
Suppliers / Packagers: see list7
Bulk Api Vendors: see list77
Clinical Trials: see list669
Patent Applications: see list9,917
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:neomycin sulfate at DailyMed

Pharmacology for Ingredient: neomycin sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer
NEOBIOTIC
neomycin sulfate
TABLET;ORAL060475-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Savage Labs
MYTREX A
neomycin sulfate; triamcinolone acetonide
OINTMENT;TOPICAL062609-001May 23, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Savage Labs
MYTREX A
neomycin sulfate; triamcinolone acetonide
CREAM;TOPICAL062598-001Jul 21, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Oman Pharm Products
NEOMYCIN SULFATE
neomycin sulfate
TABLET;ORAL065468-001Mar 29, 2010AARXNoNo► Subscribe► Subscribe► Subscribe
Alcon
STATROL
neomycin sulfate; polymyxin b sulfate
SOLUTION/DROPS;OPHTHALMIC062339-001Nov 30, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
NEOMYCIN SULFATE
neomycin sulfate
TABLET;ORAL061586-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Lannett
NEOMYCIN SULFATE
neomycin sulfate
TABLET;ORAL060607-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmaderm
NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE
neomycin sulfate; triamcinolone acetonide
OINTMENT;TOPICAL062607-001May 23, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
MYCIFRADIN
neomycin sulfate
TABLET;ORAL060520-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
MYCIFRADIN
neomycin sulfate
SOLUTION;ORAL050285-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
QuintilesIMS
Merck
Boehringer Ingelheim
Argus Health
Healthtrust
Teva
McKinsey
Fish and Richardson
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot